Ana Puhl

I am Associate Director at Collaborations Pharmaceuticals. I joined the company in 2018 and am involved in drug discovery projects for rare genetic and neglected diseases. I am passionate about drug discovery and committed to finding solutions to improve people’s lives.

My background is in protein crystallography, where I did a PhD at the University of Sao Paulo, Brazil, followed by Post-Doctoral studies at GlaxoSmithKline (USA) and the University of North Carolina (USA). Currently, at Collaborations Pharmaceuticals, I am focused on developing an enzyme replacement therapy for CLN1 Batten Disease.